Brevan Howard Capital Management »

Entrada Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $493k 48k 10.28

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
First Tr Exchange Traded Sm Cap Buywrite (FTKI)
Pdd Holdings Sponsored Ads Call Option (PDD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation Call Option (BAC)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores Call Option (WMT)
Select Sector Spdr Tr State Street Uti Call Option (XLU)

View all positions for Brevan Howard Capital Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
StepStone
Geode Capital Management
State Street Corporation
Millennium Management
Jacobs Levy Equity Management
Acadian Asset Management
Citadel Advisors
Dimensional Fund Advisors
Renaissance Technologies

View all funds holding Entrada Therapeutics